Poulvac Procerta HVT-ND
بولفاك بروسيرتا إتش في تي - إن دي
Poulvac Procerta HVT-ND is a frozen, cell-associated recombinant vaccine containing serotype 3 turkey herpesvirus (HVT) expressing the fusion (F) protein gene of Newcastle Disease Virus (NDV). Indicated for in ovo administration to 18- to 19-day-old embryonated eggs or subcutaneous injection in 1-day-old chickens as an aid in preventing Newcastle disease and Marek's disease.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
4,000-dose ampoules stored in liquid nitrogen canes
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Poultry | 0.05 mL (in ovo) or 0.2 mL (subcutaneous) | In ovo or Subcutaneous (SC) | Single application |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Poultry | 21 | 21 |
Indications
-
Aid in the prevention of Newcastle disease and Marek's disease in chickens.
-
Eliminates post-vaccinal respiratory reactions associated with live Newcastle vaccines.
Contraindications
-
Do not administer to unhealthy or stressed flocks.
Precautions
-
Extreme care required handling liquid nitrogen. Avoid exposure to skin or eyes.
-
Use within 2 hours after thawing and reconstitution.
Side Effects
-
Safe and well tolerated; no post-vaccinal respiratory reactions typical of live Newcastle vaccines.
Images
Documents
-
Download
Poulvac Procerta HVT-ND Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.